I know I mentioned this cool thing before -- but there is also a paper now!
Hell yes. If anything good has come out of this global pandemic it has been highlighting how underpowered traditional diagnostics -- and clinical medicine truly is. Time to kick some insurance companies and hospital administrators to the side and let accurate instruments like mass specs start filling bench spaces (once we confront some of our remaining demons). What better way to do it than with tons of people working on it?
Also -- tomorrow is 2 more great talks on COVID-19 proteomics from the London Proteomics Discussion Group.
Tomorrow we'll finally see the BioTyper-type MALDI-TOF analysis of SARS-CoV-2 infected materials that we've been hearing about in the media. And we get to see more targeted peptide diagnostics by LC-MRM!
You can register here! And then get your rest, cause it's ASMS for real!!!
No comments:
Post a Comment